Puneet Souda
Stock Analyst at Leerink Partners
(2.07)
# 2,663
Out of 4,818 analysts
211
Total ratings
47.4%
Success rate
-1.43%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $58.22 | +28.82% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $7.28 | +188.66% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $5.43 | -26.34% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $31.47 | +27.13% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $148.56 | +0.97% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $335.02 | +11.93% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $5.60 | +78.73% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $431.64 | +45.95% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $21.36 | +63.90% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $105.00 | +38.10% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $196.31 | +52.82% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $76.36 | +227.42% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $50.18 | +119.21% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $44.13 | +69.95% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $141.46 | +41.38% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.54 | +608.66% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.86 | +223.45% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $37.62 | -20.26% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $5.35 | +180.64% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $9.94 | +50.91% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $37.92 | +129.43% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $45.64 | +206.75% | 5 | Feb 24, 2022 |
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $58.22
Upside: +28.82%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $7.28
Upside: +188.66%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $5.43
Upside: -26.34%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $31.47
Upside: +27.13%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $148.56
Upside: +0.97%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $335.02
Upside: +11.93%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $5.60
Upside: +78.73%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $431.64
Upside: +45.95%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $21.36
Upside: +63.90%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $105.00
Upside: +38.10%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $196.31
Upside: +52.82%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $76.36
Upside: +227.42%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $50.18
Upside: +119.21%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $44.13
Upside: +69.95%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $141.46
Upside: +41.38%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.54
Upside: +608.66%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.86
Upside: +223.45%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $37.62
Upside: -20.26%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $5.35
Upside: +180.64%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $9.94
Upside: +50.91%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $37.92
Upside: +129.43%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $45.64
Upside: +206.75%